SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-12-154493
Filing Date
2012-04-09
Accepted
2012-04-09 09:55:55
Documents
2
Period of Report
2012-05-23
Effectiveness Date
2012-04-09

Document Format Files

Seq Description Document Type Size
1 NOTICE AND PROXY d308291ddef14a.htm DEF 14A 834095
2 GRAPHIC g308291g19s15.jpg GRAPHIC 10241
  Complete submission text file 0001193125-12-154493.txt   849390
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 12748969
SIC: 2836 Biological Products, (No Diagnostic Substances)